HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: Pharma
-
MODERNA TO USE mRNA FOR HIV AND CANCER AFTER COVID-19
Moderna has developed several drugs with its cost and time effective mRNA technology that are currently undergoing trials for HIV, cancer, heart diseases and genetic disorders that could potentially lead…
-
LAMBDA : NEW VARIANT WITH 7 MUTATIONS
Lambda, a new coronavirus variant has been declared as a “variant of interest” by the World Health Organization (WHO). 31 countries including United States, United Kingdom, France, Italy, Germany and…
-
INDIA ADMINISTERED OVER 32 CRORE DOSES, OVERTAKES US
Health ministry on Monday informed that as many as 32.8 crore doses of Covid-19 vaccines have been administered since the start of the vaccination drive that began from January 16….
-
NINE EUROPEAN COUNTRIES APPROVE INDIAN VACCINE COVISHIELD FOR GREEN PASS
European countries including, Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland and Spain, and Switzerland have approved the Covishield COVID-19 vaccine for ‘Green Pass’. This comes after India has asked the…
-
ZYDUS CADILA’S VACCINE TO BE JUST AS EFFECTIVE WITH A TWO- DOSE REGIMEN
Highlights: Fifth vaccine to be authorized in India. Now effective with two doses. Company to manufacture 120M doses a year. If approved, it could be World’s first plasmid DNA shot….
-
SII TO SUPPLY 20 CRORE COVAVAX DOSES BY DEC 2021
The Maryland based company, Novavax’s covid-19 vaccine candiate, named Covavax in India is all set to be launched in August-September this year in association with the Pune based Serum Institute…
-
FIRST DEATH FOLLOWING COVID-19 VACCINATION
A 68 year old man has died after being fully vaccinated with the covishield vaccine in the month of March due to anaphylaxis, which is considered as a severe allergic…
-
Concern of rising SARS-CoV2 Variants and Mutations
As new variants of SARS-Cov2 the official title given to the COVID-19 virus, continue to arise, similar transformations are discovered by the scientists, making the infection more problematic and destructive….
-
GOVERNMENT TO RESERVE 30 CRORE DOSES OF BIOLOGICAL E’S NEW VACCINE
Biological E, a Hyderabad-based vaccine and pharmaceutical company, has announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India called Corbevax…
-
NEW COVID TREATMENT IN INDIA: ANTIBODY COCKTAIL BY ROCHE AND CIPLA
The monoclonal antibody cocktail, effective against the B.1.617 variant (found in India) is being imported by Roche, a Switzerland-based leading healthcare company and marketed in India through Cipla Ltd has…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila